Article

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

2020-11-12

Abstract excerpt

COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection to severe organ damage and death. There is an urgent need for predictive markers that can guide clinical decision-making, inform about the effect of experimental therapies, and point to novel therapeutic targets. Here, we characterize the time-dependent progression of COVID-19 through different stages of the disease, by m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 04011291-2303-56e7-9a11-e61c454b886f
DOI: 10.1101/2020.11.09.20228015

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcomeDOI 10.1101/2020.11.09.20228015Read

Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsSemantic proximity Read

Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.Semantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read

COVID-19 severity is associated with immunopathology and multi-organ damageSemantic proximity Read

Dynamic gene expression analysis reveals distinct severity phases of immune and cellular dysregulation in COVID-19Semantic proximity Read

Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID.Semantic proximity Read

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsSemantic proximity Read

Predicting COVID-19 Patients Outcome Trajectories Using Proteomics and Clinical Biosignatures: A Comprehensive Machine Learning and Bioinformatics ApproachSemantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Semantic proximity Read

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19Semantic proximity Read